Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An enolase inhibitor for the targeted treatment of ENO1-deleted cancers
Yu-Hsi Lin, Nikunj Satani, Naima Hammoudi, et al.
Nature Metabolism (2020) Vol. 2, Iss. 12, pp. 1413-1426
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Targeting cancer metabolism in the era of precision oncology
Zachary E. Stine, Zachary T. Schug, Joseph M. Salvino, et al.
Nature Reviews Drug Discovery (2021) Vol. 21, Iss. 2, pp. 141-162
Open Access | Times Cited: 761
Modulating Glycolysis to Improve Cancer Therapy
Chaithanya Chelakkot, Vipin Shankar Chelakkot, Young Kee Shin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2606-2606
Open Access | Times Cited: 167
NEAT1 is essential for metabolic changes that promote breast cancer growth and metastasis
Mi Kyung Park, Li Zhang, Kyung‐Won Min, et al.
Cell Metabolism (2021) Vol. 33, Iss. 12, pp. 2380-2397.e9
Open Access | Times Cited: 143
Histone lactylation drives CD8+ T cell metabolism and function
Deblina Raychaudhuri, Pratishtha Singh, Bidisha Chakraborty, et al.
Nature Immunology (2024) Vol. 25, Iss. 11, pp. 2140-2151
Closed Access | Times Cited: 29
Lysine l-lactylation is the dominant lactylation isomer induced by glycolysis
Di Zhang, Jinjun Gao, Zhijun Zhu, et al.
Nature Chemical Biology (2024)
Open Access | Times Cited: 26
Enolase 1, a Moonlighting Protein, as a Potential Target for Cancer Treatment
Gan Qiao, Anguo Wu, Xiaoliang Chen, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 14, pp. 3981-3992
Open Access | Times Cited: 83
Mediation of PKM2-dependent glycolytic and non-glycolytic pathways by ENO2 in head and neck cancer development
Lixia Gao, Fan Yang, Dianyong Tang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 32
Synthetic Methods for Azaheterocyclic Phosphonates and Their Biological Activity: An Update 2004–2024
Martha C. Mayorquín‐Torres, Andreas Simoens, Eli Bonneure, et al.
Chemical Reviews (2024) Vol. 124, Iss. 12, pp. 7907-7975
Closed Access | Times Cited: 14
Towards next-generation treatment options to combat Plasmodium falciparum malaria
John Okombo, David A. Fidock
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 9
Cancer ENO2 Induces Histone Lactylation-Mediated M2 Macrophage Polarization and Facilitates Metastasis of Head and Neck Squamous Cell Carcinoma
Chenran Wang, Lin Tan, Maohua Huang, et al.
Engineering (2025)
Open Access | Times Cited: 1
Dynamic investigation of hypoxia-induced L-lactylation
Jinjun Gao, Ruilong Liu, Kevin Huang, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 10
Open Access | Times Cited: 1
ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapy
Chenran Wang, Maohua Huang, Yuning Lin, et al.
Nature Metabolism (2023) Vol. 5, Iss. 10, pp. 1765-1786
Closed Access | Times Cited: 20
Hypoxic microenvironment induced spatial transcriptome changes in pancreatic cancer
Huizhi Sun, Danfang Zhang, Chongbiao Huang, et al.
Cancer Biology and Medicine (2021) Vol. 18, Iss. 2, pp. 616-630
Open Access | Times Cited: 37
Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine
Yasaman Barekatain, Jeffrey J. Ackroyd, Victoria C. Yan, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 35
A map of the altered glioma metabolism
Ruhi Deshmukh, Maria Francesca Allega, Saverio Tardito
Trends in Molecular Medicine (2021) Vol. 27, Iss. 11, pp. 1045-1059
Closed Access | Times Cited: 35
Baicalein Acts against Candida albicans by Targeting Eno1 and Inhibiting Glycolysis
Liping Li, Hui Lu, Xuan Zhang, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 24
Metabolic collateral lethal target identification reveals MTHFD2 paralogue dependency in ovarian cancer
Abhinav Achreja, Tao Yu, Anjali Mittal, et al.
Nature Metabolism (2022) Vol. 4, Iss. 9, pp. 1119-1137
Closed Access | Times Cited: 23
Itraconazole inhibits tumor growth via CEBPB‐mediated glycolysis in colorectal cancer
Yong Zhang, Lu Li, Feifei Chu, et al.
Cancer Science (2024) Vol. 115, Iss. 4, pp. 1154-1169
Open Access | Times Cited: 6
Targeting Glucose Metabolism Sensitizes Pancreatic Cancer to MEK Inhibition
Yan Liang, Bo Tu, Jun Yao, et al.
Cancer Research (2021) Vol. 81, Iss. 15, pp. 4054-4065
Open Access | Times Cited: 32
Targeting Energy Metabolism in Cancer Treatment
Joanna Kubik, Ewelina Humeniuk, Grzegorz Adamczuk, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5572-5572
Open Access | Times Cited: 21
ENO1 regulates trastuzumab resistance in gastric cancer cells through IRP1
Lei Wang, X. H. Ding, Jiayi Yang, et al.
Gastrointestinal Tumors (2025) Vol. 12, Iss. 1
Open Access
Mitochondrial-Encoded Complex I Impairment Induces a Targetable Dependency on Aerobic Fermentation in Hürthle Cell Carcinoma of the Thyroid
Anderson R. Frank, Vicky Li, Spencer D. Shelton, et al.
Cancer Discovery (2023) Vol. 13, Iss. 8, pp. 1884-1903
Open Access | Times Cited: 9
Beyond ENO1, emerging roles and targeting strategies of other enolases in cancers
J. M. Ni, Yihui Huang, Chaoqun Li, et al.
Molecular Therapy — Oncolytics (2023) Vol. 31, pp. 100750-100750
Open Access | Times Cited: 9
Enolase inhibitors as therapeutic leads for Naegleria fowleri infection
Jillian E. Milanes, Victoria C. Yan, Cong-Dat Pham, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 8, pp. e1012412-e1012412
Open Access | Times Cited: 3
Impaired anaplerosis is a major contributor to glycolysis inhibitor toxicity in glioma
Sunada Khadka, Kenisha Arthur, Yasaman Barekatain, et al.
Cancer & Metabolism (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top